Skip to main content
. Author manuscript; available in PMC: 2020 Mar 1.
Published in final edited form as: Reprod Toxicol. 2018 Dec 27;84:32–38. doi: 10.1016/j.reprotox.2018.12.008

Table 3.

Reproductive outcomes in third generation women, according to their mother’s prenatal DES exposure status.

Baseline Follow-up
Mother’s prenatal DES exposure status Mother’s prenatal DES exposure status
Outcome Exposed

(n =796)
No. (%)
Unexposed

(n = 469)
No. (%)
PRa (95% CI) Exposed

(n = 381)
No. (%)
Unexposed

(n = 280)
No. (%)
RRb (95% CI)
Ever been pregnant
 No 588 (74.0) 304 (64.8) 144 (44.2)   87 (38.7)
 Yes 207 (26.0) 165 (35.2) 0.91 (0.86,0.97) 182 (55.8) 138 (61.3) 0.99 (0.92,1.06)
Ever had a live birthc
No   64 (31.2)   48 (29.3)   18 (9.9)   22 (15.9)
 Yes 141 (68.8) 116 (70.7) 1.04 (0.87,1.25) 164 (90.1) 116 (84.1) 1.08 (1.00, 1.16)
Ever have an adverse pregnancy outcomed
 No 142 (68.6) 118 (71.5) 129 (70.9) 98 (71.0)
 Yes   65 (31.4)   47 (28.5) 1.12 (0.87,1.44)   53 (29.1)   40 (29.0) 1.01 (0.72,1.41)
 Miscarriaged   48 (23.2)   36 (21.8) 1.06 (0.75,1.50)   31 (17.0)   29 (21.0) 0.80 (0.40,1.63)
 Preterm deliveryd   21 (10.1)   14 (8.5) 1.31 (0.81,2.10)   22 (12.1)   11 (8.0) 1.54 (1.35,1.75)
 Ectopicd     6 (2.9)     3 (1.8) 1.57 (0.41,5.95)     7 (3.9)     1 (0.7) 6.00 (0.45,78.3)
Infertility
 No 757 (95.3) 448 (95.5) 345 (91.0) 246 (88.2)
 Yes   37 (4.7)   21 (4.5) 1.53 (0.92,2.53)   34 (9.0)   33 (11.8) 0.85 (0.56, 1.29)
Sought medical help for infertility
 No 764 (96.2) 449 (95.7) 336 (88.4) 253 (90.7)
 Yes   30 (3.8)   20 (4.3) 1.38 (0.83,2.28)   44 (11.6)   26 (9.3) 1.49 (0.89,2.49)

Abbreviations: DES, diethylstilbestrol; PR, prevalence ratios; RR, risk ratios; CI, confidence intervals.

a

For outcomes prevalent at baseline, adjusted for age and cohort.

b

For new events occurring during follow-up, adjusted for age and cohort.

c

All pregnancy outcomes assessed among women who were ever pregnant.

d

The denominator for calculating percents is the number of women ever pregnant.